Browse > Article
http://dx.doi.org/10.5536/KJPS.2008.35.1.039

Infection and Pathogenesis Mechanisms of Marek's Disease Virus  

Jang, H.K. (Department of Infectious Diseases and Avian Diseases, College of Veterinary.Medicine, Chonbuk National University)
Park, Y.M. (Department of Infectious Diseases and Avian Diseases, College of Veterinary.Medicine, Chonbuk National University)
Cha, S.Y. (Department of Infectious Diseases and Avian Diseases, College of Veterinary.Medicine, Chonbuk National University)
Park, J.B. (Department of Infectious Diseases and Avian Diseases, College of Veterinary.Medicine, Chonbuk National University)
Publication Information
Korean Journal of Poultry Science / v.35, no.1, 2008 , pp. 39-55 More about this Journal
Abstract
Like the other herpesviruses, the virion of MDV consists of an envelope, which surrounds an amorphous tegument. Within the tegument, and icosahedral capsid encloses a linear double-stranded DNA core. Although the genome structure of MDV indicates that it is an ${\alpha}-herpesvirus$ like herpes simplex and varicella-zoster viruses, biological properties indicate MDV is more akin to the ${\gamma}-herpesvirus$ group, which includes Epstein-Barr and Kaposi's sarcoma herpesviruses. These herpesviruses replicate lytically in lymphocytes, epithelial and fibroblastic cells, and persist in lymphoblastoid cells. MDV has a complex life cycle and uses two means of replication, productive and non-productive, to exist and propagate. The method of reproduction changes according to a defined pattern depending on changes in virus-cell interactions at different stages of the disease, and in different tissues. Productive (lytic) interactions involve active invasion and take-over of the host cell, resulting in the production of infectious progeny virions. However, some herpesviruses, including MDV, can also establish a non-productive (abortive) infection in certain cell types, resulting in production of cell-associated progeny virus. Non-productive interactions represent persistent infection, in which the viral genome is present but gene expression is limited, there is no structural or regulatory gene translation, no replication, no release of progeny virions and no cell death. Reactivation of the virus is rare, and usually the infectious virus can be re-isolated only after cultivation in vitro. MDV establishes latency in lymphoid cells, some of which are subsequently transformed. In this review article, recent knowledges of the pathogenesis mechanisms followed by MDV infection to sensitive cells and chickens are discussed precisely.
Keywords
Marek's disease; Marek's disease virus; MDV; herpesvirus; pathogenesis; virus-cell interaction;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Afonso CL, Tulman ER, Lu Z, Zsak L, Rock DL, Kutish GF 2001 The genome of herpesvirus of turkey. J Virol 75:971-978   DOI   ScienceOn
2 Baigent SJ, Petherbridge LJ, Howes K, Smith LP, Currie RJ, Nair VK 2005 Absolute quantitation of Marek's disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. J Virol Methods 123:53-64   DOI   ScienceOn
3 Buckmaster AE, Scott SD, Sanderson MJ, Boursnell ME, Ross NL, Binns MM 1988 Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: Implications for herpesvirus classification. J Gen Virol 69:2033-2042   DOI   ScienceOn
4 Burgess SC, Basaran BH, Davison TF 2001 Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype. Vet Pathol 38:129-412   DOI   ScienceOn
5 Calnek BW, Schat KA, Ross LJ, Chen CL 1984b Further characterization of Marek's disease virus-infected lymphocytes. II. In vitro infection. Int J Cancer 33:399-406   DOI
6 Davidson I, Borenshtain R 2003 Novel applications of feather tip extracts from MDV-infected chickens: Diagnosis of commercial broilers, whole genome separation by PFGE and synchronic mucosal infection. FEMS Immunol Med Microbiol 38:199-203   DOI   ScienceOn
7 Dorange F, Tischer BK, Vautherot JF, Osterrieder N 2002 Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth. J Virol 76:1959-1970   DOI
8 Hayashi M, Io K, Furuichi T, Ren S, Isogai E, Watanabe T, Namioka S 1995 Changes in the nucleosomal structure of the Marek's disease virus genome in lymphoblastoid cell line MDCC-MSB1 induced by 5-azacytidine. J Vet Med Sci 57: 157-160   DOI   ScienceOn
9 Handberg KJ, Nielsen OL, Jorgensen PH, 2001 The use of serotype 1- and serotype 3-specific polymerase chain reaction for the detection of Marek's disease virus in chickens. Avian Pathol 30:243-249   DOI   ScienceOn
10 Hong Y, Coussens PM 1994 Identification of an immediateearly gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide. J Virol 68:3593-3603
11 Izumiya Y, Jang HK, Ono M, Mikami T 2001 A complete genomic DNA sequence of Marek's disease virus type 2, strain HPRS24. Curr Top Microbiol Immunol 255:191-221
12 Kaschka-Dierich C, Nazerian K, Thomssen R 1979 Intracellular state of Marek's disease virus DNA in two tumour-derived chicken cell lines. J Gen Virol 44:271-280   DOI   ScienceOn
13 Lee LF, Wu P, Sui D, Ren D, Kamil J, Kung HJ, Witter RL 2000 The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc Natl Acad Sci USA 97:6091-6096
14 Le Rouzic E, Thoraval P, Afanassieff M, Cherel Y, Dambrine G, Perbal B 2002 Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line. Mol Pathol 55:262-272   DOI
15 Parcells MS, Lin SF, Dienglewicz RL, Majerciak V, Robinson DR, Chen HC, Wu Z, Dubyak GR, Brunovskis P, Hunt HD, Lee LF, Kung HJ 2001 Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J Virol 75:5159-5173   DOI   ScienceOn
16 Moore FR, Schat KA, Hutchison N, Leciel C, Bloom SE 1993 Consistent chromosomal aberration in cell lines transformed with Marek's disease herpesvirus: evidence of genomic DNA amplification. Int J Cancer 54:685-692   DOI   ScienceOn
17 Nazerian K, Sharma JM 1975 Detection of T-cell surface antigens in a Marek's disease lymphoblastoid cell line. J Natl Cancer Inst 54:277-279   DOI
18 Niikura M, Witter RL, Jang HK, Ono M, Mikami T, Silva RF 1999 MDV glycoprotein D is expressed in the feather follicle epithelium of infected chickens. Acta Virol 43:159-163
19 Peng Q, Zeng M, Bhuiyan ZA, Ubukata E, Tanaka A, Nonoyama M, Shirazi Y 1995 Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHII2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV. Virology 213:590-599   DOI   ScienceOn
20 Secombes CJ, Kaiser P 2003 The phylogeny of cytokines. Pages 57-84 In: The Cytokine Handbook. Thomson AW, Lotze MT (Ed.) Elsevier, London
21 Shigekane H, Kawaguchi Y, Shirakata M, Sakaguchi M, Hirai K 1999 The bi-directional transcriptional promoters for the latency-relating transcripts of the pp38/pp24 mRNAs and the 1.8 kb-mRNA in the long inverted repeats of Marek's disease virus serotype 1 DNA are regulated by common promoter- specific enhancers. Arch Virol 144:1893-1907   DOI   ScienceOn
22 Sugaya K, Bradley G, Nonoyama M, Tanaka A 1990 Latent transcripts of Marek's disease virus are clustered in the short and long repeat regions. J Virol 64:5773-5782
23 Parcells MS, Dienglewicz RL, Anderson AS, Morgan RW 1999 Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome. J Virol 73:1362-1373
24 Tischer BK, Schumacher D, Messerle M, Wagner M, Osterrieder N 2002 The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J Gen Virol 83:997-1003   DOI
25 Witter RL 1997 Increased virulence of Marek's disease virus field isolates. Avian Dis 41:149-163   DOI   ScienceOn
26 Wu P, Reed WM, Lee LF 2001 Glycoproteins H and L of Marek's disease virus form a hetero-oligomer essential for translocation and cell surface expression. Arch Virol 146: 983-992   DOI
27 Fynan EF, Ewert DL, Block TM 1993 Latency and reactivation of Marek's disease virus in B lymphocytes transformed by avian leukosis virus. J Gen Virol 74:2163-2170   DOI   ScienceOn
28 Ohashi K, Zhou W, O'Connell PH, Schat KA 1994 Characterization of a Marek's disease virus BamHI-L-specific cDNA clone obtained from a Marek's disease lymphoblastoid cell line. J Virol 68:1191-1195
29 Damania B, Jung JU 2001 Comparative analysis of the transforming mechanisms of Epstein-Barr virus, Kaposi's sarcoma- associated herpesvirus, and Herpesvirus saimiri. Adv Cancer Res 80:51-82   DOI
30 Calnek BW, Schat KA, Ross LJ, Shek WR, Chen CL 1984a Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection. Int J Cancer 33:389-398   DOI
31 Addinger HK, Calnek BW 1973 Pathogenesis of Marek's disease: early distribution of virus and viral antigens in infected chickens. J Natl Cancer Inst 50:1287-1298   DOI
32 Calnek BW 1986 Marek's disease: A model for herpesvirus oncology. Crit Rev Microbiol 12:293-320   DOI
33 Calnek BW, Lucio B, Schat KA, Lillehoj HS 1989 Pathogenesis of Marek's disease virus-induced local lesions. 1. Lesion characterization and cell line establishment. Avian Dis 33: 291-302   DOI   ScienceOn
34 Buscaglia C, Calnek BW 1988b Maintenance of Marek's disease herpesvirus latency in vitro by a factor found in conditioned medium. J Gen Virol 69:2809-2818   DOI   ScienceOn
35 Carrozza JH, Fredrickson TN, Prince RP, Luginbuhl RE 1973 Role of desquamated epithelial cells in transmission of Marek's disease. Avian Dis 17:767-781   DOI   ScienceOn
36 Shek WR, Calnek BW, Schat KA, Chen CH 1983 Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells. J Natl Cancer Inst 70:485-491
37 Tulman ER, Afonso CL, Lu Z, Zsak L, Rock DL, Kutish GF 2000 The genome of a very virulent Marek's disease virus. J Virol 74:7980-7988   DOI
38 Witter RL 1983 Characteristics of Marek's disease viruses isolated from vaccinated commercial chicken flocks: Association of viral pathotype with lymphoma frequency. Avian Dis 27:113-132   DOI   ScienceOn
39 Witter RL, Calnek BW, Buscaglia C, Gimeno IM, Schat KA 2005 Classification of Marek's disease viruses according to pathotype: Philosophy and methodology. Avian Pathol 34: 75-90   DOI   ScienceOn
40 Beasley JN, Patterson LT, McWade DH 1970 Transmission of Marek's disease by poultry house dust and chicken dander. Am J Vet Res 31:339-344
41 Baigent SJ, Davison TF 2004. Marek's disease virus: biology and life cycle. Pages 62-77 In: Marek's disease (an evolving problem). Davison F and Nair V, (Ed.) Elsevier Academic Press, New York
42 Delecluse HJ, Schuller S, Hammerschmidt W 1993b Latent Marek's disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells. EMBO J 12:3277-3286
43 Payne LN, Rennie M 1976 The proportions of B and T lymphocytes in lymphomas, peripheral nerves and lymphoid organs in Marek's disease. Avian Pathol 5:147-154   DOI
44 Baaten BJ, Butter C, Davison TF 2004 Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease. Vet Immunol Immunopathol 100:165-177   DOI   ScienceOn
45 Jeurissen SH, Scholten R, Hilgers LA, Pol JM, De Boer GF 1989b In situ detection by monoclonal antibody D-35.1 of cells infected with Marek's disease virus that interact with splenic ellipsoid-associated reticulum cells. Avian Dis 33: 657-663   DOI   ScienceOn
46 Baigent SJ, Ross LJ, Davison TF 1998 Differential susceptibility to Marek's disease is associated with differences in number, but not phenotype or location, of pp38+ lymphocytes. J Gen Virol 79:2795-2802   DOI
47 Ichijo K, Isogai H, Okada K, Fujimoto Y 1981 Initial proliferation site of Marek's disease tumor cells in the spleen. Zentralbl Veterinarmed B 28:177-189
48 Masuyama J, Berman JS, Cruikshank WW, Morimoto C, Center DM 1992 Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J Immunol 148:1367-1374
49 Parcells MS, Arumugaswami V, Prigge JT, Pandya K, Dienglewicz RL 2003 Marek's disease virus reactivation from latency: Changes in gene expression at the origin of replication. Poult Sci 82:893-898   DOI
50 Schat KA, Chen CL, Calnek BW, Char D 1991 Transformation of T-lymphocyte subsets by Marek's disease herpesvirus. J Virol 65:1408-1413
51 Calnek BW 2001 Pathogenesis of Marek's disease virus infection. Pages 25-55 In: Marek's Disease. Hirai K, (Ed.) Springer, Berlin, Germany
52 Rouse BT, Wells RJ, Warner NL 1973 Proportion of T and B lymphocytes in lesions of Marek's disease: theoretical implications for pathogenesis. J Immunol 110:534-539
53 Schat KA, Lucio B, Carlisle JC 1981a Pathogenesis of infectious bursal disease in embryonally bursectomized chickens. Avian Dis 25:996-1004   DOI   ScienceOn
54 Payne LN 2004 Pathological responses to infection. Pages 78- 97 In: Marek's Disease (an evolving problem). Davison F and Nair V, (Ed.) Elsevier Academic Press, New York
55 Cantello JL, Parcells MS, Anderson AS, Morgan RW 1997 Marek's disease virus latency-associated transcripts belong to a family of spliced RNAs that are antisense to the ICP4 homolog gene. J Virol 71:1353-1361
56 Xing Z, Schat KA 2000 Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. J Virol 74:3605-3612   DOI
57 Baigent SJ, Davison TF 1999 Development and composition of lymphoid lesions in the spleens of Marek's disease virus-infected chickens: association with virus spread and the pathogenesis of Marek's disease. Avian Pathol 28:287-300   DOI
58 Islam AF, Walkden-Brown SW, Groves PJ, Underwood GJ 2007 Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge. Aust Vet J 85:348-355   DOI   ScienceOn
59 Buscaglia C, Calnek BW, Schat KA 1988a Effect of immunocompetence on the establishment and maintenance of latency with Marek's disease herpesvirus. J Gen Virol 69: 1067-1077   DOI   ScienceOn
60 Delecluse HJ, Hammerschmidt W 1993a Status of Marek's disease virus in established lymphoma cell lines: herpesvirus integration is common. J Virol 67:82-92
61 Barrow AD, Burgess SC, Baigent SJ, Howes K, Nair VK 2003 Infection of macrophages by a lymphotropic herpesvirus: A new tropism for Marek's disease virus. J Gen Virol 84:2635- 2645   DOI   ScienceOn
62 Burgess SC, Davison TF 2002 Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37. J Virol 76:7276-7292   DOI
63 Cui ZZ, Lee LF, Liu JL, Kung HJ 1991 Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. J Virol 65:6509-6515
64 Schat KA 1981b Role of the spleen in the pathogenesis of Marek's disease. Avian Pathol 10:171-182   DOI   ScienceOn
65 Burgess SC, Davison TF 1999 A quantitative duplex PCR technique for measuring amounts of cell-associated Marek's disease virus: Differences in two populations of lymphoma cells. J Virol Methods 82:27-37   DOI   ScienceOn
66 Cui ZZ, Yan D, Lee LF 1990 Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins. Virus Genes 3:309-322   DOI
67 Cantello JL, Anderson AS, Morgan RW 1994 Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus. J Virol 68:6280-6290
68 Ross N, O'Sullivan G, Rothwell C, Smith G, Burgess SC, Rennie M, Lee LF, Davison TF 1997 Marek's disease virus EcoRIQ gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek's disease lymphomas. J Gen Virol 78:2191-2198   DOI
69 Schat KA, Chen CL, Shek WR, Calnek BW 1982 Surface antigens on Marek's disease lymphoblastoid tumor cell lines. J Natl Cancer Inst 69:715-720
70 Schumacher D, Tischer BK, Reddy SM, Osterrieder N 2001 Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J Virol 75: 11307-11318   DOI   ScienceOn
71 Jones D, Lee L, Liu JL, Kung HJ, Tillotson JK 1992 Marek's disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc Natl Acad Sci USA 89:4042-4046
72 Kung HJ, Xia L, Brunovskis P, Li D, Liu JL, Lee LF 2001 Meq: an MDV-specific bZIP transactivator with transforming properties. Pages 245-260 In: Marek's Disease. Hirai K, (Ed.) Springer, Berlin, Germany
73 Morimura T 1993 Involvement of $CD4^+$ T cell in the protective effects of Marek's disease vaccines. Jpn J Vet Res 41:34-35
74 Jeurissen SH, Janse EM, Kok GL, De Boer GF 1989a Distribution and function of non-lymphoid cells positive for monoclonal antibody CVI-ChNL-68.2 in healthy chickens and those infected with Marek's disease virus. Vet Immunol Immunopathol 22:123-133   DOI   ScienceOn